Interventions to manage occluded central venous access devices: An umbrella review

被引:1
|
作者
Elliott, Jessica [1 ,2 ]
Ng, Linda [1 ,2 ]
Meredith, Carolyn [3 ]
Mander, Gordon [4 ,5 ,6 ]
Thompson, Murray [7 ]
Reynolds, Lorraine [6 ]
机构
[1] Univ Southern Queensland, Sch Nursing & Midwifery, Salisbury Rd, Ipswich, Qld 4305, Australia
[2] Univ Southern Queensland, Ctr Hlth Res, Ipswich, Qld, Australia
[3] Darling Downs Hlth, Nursing & Midwifery Educ & Training, Toowoomba, Qld, Australia
[4] Univ Queensland, Fac Hlth & Behav Sci, Southern Queensland Rural Hlth SQRH, Toowoomba, Qld, Australia
[5] Queensland Univ Technol QUT, Fac Hlth, Sch Clin Sci, Brisbane, Qld, Australia
[6] Toowoomba Hosp, Dept Med Imaging, Darling Downs Hlth, Queensland Hlth, Toowoomba, Qld, Australia
[7] Darling Downs Hlth, Med Workforce, Toowoomba, Qld, Australia
来源
关键词
Catheter occlusion; vascular access devices; catheterisation; peripheral; totally implantable central venous access devices; umbrella review; systematic review; CATHETER USE; COMPLICATIONS; THROMBOSIS; IMPACT;
D O I
10.1177/11297298241246092
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The main objective of this umbrella review is to synthesise available evidence from systematic reviews on the effectiveness of interventions for the management of occlusions in central venous access devices. CVADS have been extensively utilised among the critically ill since the 1950s however have also been linked to an increase in catheter complications. CVAD occlusion can occur in 14%-36% of patients within 1-2 years of catheter placement and is a longstanding complication. Umbrella methodology was applied to review five healthcare databases. Databases were searched for publications from 2009 and 2022 and electronic keywords searches were conducted. The authors searched for reviews that reported on any intervention to prevent, maintain or manage patency of the central venous access devices within an acute care setting. Of the 278 articles identified from the initial search a total of 11 articles were identified. This umbrella review concluded that education enhances patient outcomes and decreases occlusion rates. Further studies are required to explore occlusion reduction strategies in relation to flushing and locking.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Phase II trial of alfimeprase, a novel-acting fibrin degradation agent, for occluded central venous access devices
    Moll, Stephan
    Kenyon, Peter
    Bertoli, Luigi
    De Maio, James
    Homesley, Howard
    Deitcher, Steven R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3056 - 3060
  • [22] Obtaining Coagulation Blood Samples From Central Venous Access Devices: A Review of the Literature
    Dalton, Kerri A.
    Aucoin, Julia
    Meyer, Britt
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2015, 19 (04) : 418 - 423
  • [23] Review of the radiation exposure during screening of surgically implanted central venous access devices
    Friend, Jikol
    Lindsey-Temple, Suzanna
    Gollow, Ian
    Whan, Elizabeth
    Gera, Parshotam
    JOURNAL OF PEDIATRIC SURGERY, 2015, 50 (07) : 1214 - 1219
  • [24] Complications associated with the use of central venous access devices
    Whitman, ED
    CURRENT PROBLEMS IN SURGERY, 1996, 33 (04) : 313 - 378
  • [25] Central venous access devices in children with hemophilia: an update
    Blanchette, VS
    AlMusa, A
    Stain, AM
    Ingram, J
    Fille, RM
    BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 : S11 - S14
  • [26] Central venous access in children: indications, devices, and risks
    Ares, Guillermo
    Hunter, Catherine J.
    CURRENT OPINION IN PEDIATRICS, 2017, 29 (03) : 340 - 346
  • [27] Temporary acute care central venous access devices
    Namyslowski, J
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 1998, 15 (03) : 253 - 257
  • [28] Understanding percutaneous and subcutaneous central venous access devices
    Luckianow, Gina M.
    Smith, David
    Bullen, David
    Kaplan, Lewis J.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2016, 29 (01): : 33 - 36
  • [29] Recombinant urokinase for restoration of patency in occluded central venous access devices - A double-blind, placebo-controlled trial
    Haire, WD
    Deitcher, SR
    Mullane, KM
    Jaff, MR
    Firszt, CM
    Schulz, GA
    Schuerr, DM
    Schwartz, LB
    Mouginis, TL
    Barton, RP
    THROMBOSIS AND HAEMOSTASIS, 2004, 92 (03) : 575 - 582
  • [30] Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: A multiple-center, international trial
    Svoboda, P
    Barton, P
    Barbarash, OL
    Butylin, AA
    Jacobs, BR
    Lata, J
    Haire, WD
    Jaff, MR
    Firszt, CM
    Mouginis, TL
    Schuerr, DM
    Schulz, GA
    Schwartz, LB
    El-Shahawy, MA
    CRITICAL CARE MEDICINE, 2004, 32 (10) : 1990 - 1996